Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. - Wikidata - awgldk - TriplyDB

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

http://www.wikidata.org/entity/Q33429461

about

Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy.TAFRO Syndrome Associated with EBV and Successful Triple Therapy Treatment: Case Report and Review of the Literature.International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome Castleman's disease with TAFRO syndrome: a case report from Syria Anasarca, Fever, Thrombocytopenia, Organomegaly, and Multiorgan Failure in a 24-Year-Old Pregnant Woman.Multicentric Castleman disease: Where are we now?Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease.A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.The full spectrum of Castleman disease: 273 patients studied over 20 years.TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome.TAFRO syndrome: current perspectives.Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.Nephrotic Syndrome with Thrombocytopenia, Lymphadenopathy, Systemic Inflammation, and Splenomegaly.Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman's disease.TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements.Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas

P2860

Q32182008-B4FFE2E2-25F7-452E-986A-BF7151207B0F Q33432624-A794F0F7-629C-46D7-AE15-1B9B5086C294 Q33436275-35024E2B-9384-4144-8A15-61BBD59A3790 Q33438403-7DC7158D-903E-4FBF-98EF-92B1D4BC735B Q33438812-077FDFFB-D4FF-4AFC-B4CD-F9DA02318702 Q33439399-02214CEE-2E51-4029-B3DC-2C384C43A91A Q33440516-5D237841-57F2-4FFD-8A01-B51B78ADB9D7 Q33441886-DFB34C77-E1B0-4652-8183-A61F908A07F8 Q33442420-16A75B95-6F40-4F66-8BB4-CDC8FCA6961B Q33443714-620FE1FE-4CC6-47F0-93A4-FFCB8C6266A6 Q38863770-514C2654-2F65-4FCA-BB6A-86875E9E496A Q40042816-7F2ED313-CA89-4ECF-A6CD-5DE6BFDE5207 Q40366614-8083AD53-DF32-493B-99EE-7928124D21BA Q41678341-A859B36D-440B-43E5-94AB-6452B85F2995 Q41928746-C5588576-5845-4083-AE37-D3F285F9C35C Q42364525-ED832F73-7FE2-4319-AEBF-68368F8162C7 Q47578601-61A4BF25-EF02-476E-A2A9-BC36B3FCC990 Q47669677-371D61BB-0F04-41FB-8586-185A5FB263BC Q48221132-80330CB6-316A-4C9F-BF36-9348BA95B757 Q49384282-AA8900AA-3178-4333-8C4E-501000611D9F Q49487524-B4C79F4B-90B3-457F-A0E5-92EABBAD1F99 Q50101690-EA8BE879-7E7B-4437-84CA-C110FFF270D3 Q52720139-1006B84B-56F4-47B9-A01E-FC1527F1A199 Q54594948-33EC20F3-73D3-4770-81E8-CD4ED4DA5E19 Q54684652-6A375A85-8CC6-4C83-9B4B-48D508BF90E3 Q54988723-B833211C-AAD3-4E1C-8139-C6AA04BF78F0 Q55024047-972D62B7-3851-4DFB-A44C-BF6E1689958B Q55265167-39DAC257-4663-458B-B11A-A67288BFD01B Q55407039-F448823C-B463-4FF4-93D9-57DBF112725F Q56594773-432EB7C4-F8A0-436C-A9E7-0C2BAC0F94FC

P2860

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

http://www.wikidata.org/entity/Q33429461

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Clinicopathologic analysis of ...... ulticentric Castleman disease.

@ast

Clinicopathologic analysis of ...... ulticentric Castleman disease.

@en

type

label

Clinicopathologic analysis of ...... ulticentric Castleman disease.

@ast

Clinicopathologic analysis of ...... ulticentric Castleman disease.

@en

prefLabel

Clinicopathologic analysis of ...... ulticentric Castleman disease.

@ast

Clinicopathologic analysis of ...... ulticentric Castleman disease.

@en

P1433

Q33429461-302BA08A-1567-4817-AF84-A1B3720D5766

P1476

Q33429461-B75DAE82-C076-4888-875D-ADB0DC1491FD

P2093

Q33429461-13B923C6-E83F-424C-9AF3-190AF47E9451

Q33429461-31398CDE-95D0-4C70-AFCE-BE69E9954D60

Q33429461-339BB54E-A83F-4E30-B48F-CBC5AA2895C2

Q33429461-42D6CFFE-A86E-4F18-931B-C0E3301F36C5

Q33429461-4663366B-FC1C-4A52-8553-6BC13A4C0625

Q33429461-5D07E568-D036-49E8-83BE-EF5F645FE35C

Q33429461-6A82A747-9653-48BC-B3D9-4FCD4923D344

Q33429461-6D30DFB3-1C95-40D7-821E-C066756FE3BE

Q33429461-86BE5622-28DF-4DD3-ABE1-F85BB7782C9F

Q33429461-8AF334CC-1ECB-4CD4-AE5F-22854417F5FE

P2860

Q33429461-051B7437-8008-455E-A93B-505F7E65CCF9

Q33429461-0A4C215E-57F5-4EEE-A1C1-D96F19A0CCF6

Q33429461-1F344586-64AA-4EA6-903C-AD95EC7A7AA7

Q33429461-36E427C4-9829-4567-B76F-2F435324D5B4

Q33429461-4620DFE2-29B1-468C-B778-15B91DE7F111

Q33429461-528542AF-7CAD-4BF3-8102-F07AE0DC7392

Q33429461-533E93D6-4803-44D0-ADCA-466B77A4A9F7

Q33429461-691877E2-DB1C-4891-9565-C7ECE3ABF039

Q33429461-6D5E8EF3-3F85-4943-925C-6D64FCED3138

Q33429461-6F1C2A5C-0FE4-4A13-9E3E-B8E7A392666D

P304

Q33429461-04EDA2B5-DDCD-42D3-A4A0-2B884C6FA777

P31

Q33429461-96BDD83B-9357-4080-AE23-D96E62356726

P356

Q33429461-CE5D4369-644D-48D0-BC10-2C8490CD6680

P433

Q33429461-725558D8-8F90-4109-A939-BFD6DBBE4FEA

P478

Q33429461-D23D2F78-315E-4804-A069-947D2113E5A9

P50

Q33429461-06003772-AB1B-496F-9E67-D246065D9ECE

Q33429461-8DCA241B-E9EC-4282-991C-B7EB4C62BE5A

Q33429461-D138CEF0-D037-4748-9C55-A5108251EF5D

P577

Q33429461-CD1638F7-F394-4EB2-AA7F-C5A51A9DCFF1

P698

Q33429461-5B216EC9-D9BF-443E-8DDE-2523C5847521

P356

P1433

American Journal of Hematology

P1476

Clinicopathologic analysis of ...... multicentric Castleman disease

@en

P2093

Akio Saito

http://www.w3.org/2001/XMLSchema#string

Christopher S Nabel

http://www.w3.org/2001/XMLSchema#string

Isao Yoshida

http://www.w3.org/2001/XMLSchema#string

Kazue Takai

http://www.w3.org/2001/XMLSchema#string

Kenji Yokota

http://www.w3.org/2001/XMLSchema#string

Koji Nikkuni

http://www.w3.org/2001/XMLSchema#string

Kosei Matsue

http://www.w3.org/2001/XMLSchema#string

Masao Hagihara

http://www.w3.org/2001/XMLSchema#string

Masataka Okamoto

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Kawano

http://www.w3.org/2001/XMLSchema#string

P2860

The 1982 revised criteria for the classification of systemic lupus erythematosus

Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases.

Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.

Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.

A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease

P304

220-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24242

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

David Fajgenbaum

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26805758

http://www.w3.org/2001/XMLSchema#string